search
Back to results

Value of Gym-based Exercise Training for Young Adults Receiving Antipsychotic Medication: The Vega Trial (Vega)

Primary Purpose

Affective Disorder, Psychosis

Status
Recruiting
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Supervised exercise
Sponsored by
Rigshospitalet, Denmark
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Affective Disorder

Eligibility Criteria

18 Years - 35 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • diagnosed with a psychotic disorder (F20-F29 Schizophrenia, schizotypal and delusional disorders) or an affective disorder (F30-F39 Mood [affective] disorders)
  • treated with antipsychotic medication (any dose) for at least one month
  • able to read and speak Danish

Exclusion Criteria:

  • advised from participating in exercise training by their treating doctor

Sites / Locations

  • Aalborg University HospitalRecruiting
  • Aarhus University Hospital
  • Mental Health Centre CopenhagenRecruiting
  • Mental Health Centre GlostrupRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Vega Exercise Community

Usual care

Arm Description

Participants will be offered one hour of tailored supervised, gym-based exercise training three times per week for a period of four months. In addition, participants are offered free-of-charge membership to the gym for six months and are invited to take part in training classes and use fitness equipment provided by the gym to regular members. The supervised program is tailored to meet the needs and requirements of this particular group of young adults and will include three weekly sessions of moderate-to-high intensity and mobility exercises.

Participants will receive treatment as usual and be informed of the official physical activity guidelines as part of the information on group allocation. Moreover, they will be advised to continue their daily living, as they normally would do, not guiding them to other interventions neither preventing them to do so. In addition, participants in the usual care group will be given a subsidized membership including access to the exercise classes for four months after the 12 months follow up.

Outcomes

Primary Outcome Measures

Personal recovery
15-item Questionnaire about the Process of Recovery

Secondary Outcome Measures

Personal recovery
15-item Questionnaire about the Process of Recovery
Mental health
Mental Component Summary from the Short-Form 12 (SF-12) Health survey
Health-related quality of life
Short-Form 12 (SF-12) Health survey
Affective symptoms
Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional distress
Physical Activity
International Physical Activity Questionnaire short form (IPAQ-SF)
Internalized Stigma
Internalized Stigma of Mental Illness Inventory (ISMI-9) short form
Use of substance (alcohol, cannabis, drugs)
Measured by self-developed items with responses for each substance: "never used", "use less than once a month", "regular use", "harmful use"
Sleep
Brief Pittsburgh Sleep Quality Index (B-PSQI)
Positive and negative symptoms
Colorado Symptom Index (MCSI)
Loneliness
Measured by a single item on a Likert scale of 4 levels: "During the past 12 months, have you felt lonely?"
Abdominal circumference
Measured with tape measure
Body weight
Measured on a scale
Skeletal muscle mass
Measured by bioimpedance
Total body fat
Measured by bioimpedance
Cardiorespiratory fitness
measured with the modified Ekblom-Bak submaximal cycle ergometer test
Blood pressure
measured by a digital blood pressure monitor
Resting heart rate
measured by a heart rate monitor
High density lipoproteins (HDL)
Taken from routine blood tests (mmol/l)
Low density lipoproteins (LDL)
Taken from routine blood tests (mmol/l)
Triglycerides
Taken from routine blood tests (mmol/l)
Glycosylated haemoglobin (HbA1c)
Taken from routine blood tests (mmol/l)
C-reactive protein (CRP)
Taken from routine blood tests (mg/L)

Full Information

First Posted
June 29, 2022
Last Updated
October 25, 2022
Sponsor
Rigshospitalet, Denmark
Collaborators
Aarhus University Hospital, Aalborg University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05461885
Brief Title
Value of Gym-based Exercise Training for Young Adults Receiving Antipsychotic Medication: The Vega Trial
Acronym
Vega
Official Title
Value of Gym-based Exercise Training for Young Adults Receiving Antipsychotic Medication: A Pragmatic, Single-blinded, Multicenter Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
October 25, 2022 (Actual)
Primary Completion Date
January 2025 (Anticipated)
Study Completion Date
October 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rigshospitalet, Denmark
Collaborators
Aarhus University Hospital, Aalborg University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a multicentre, pragmatic, randomised controlled trial to estimate the effect of a 4-month gym-based exercise training program on 1) patient-rated personal recovery (primary outcome), 2) Health-related quality of life, behavioral and functional symptoms, and cardiometabolic risk factors (secondary outcomes) in young adults with psychotic disorders. Four-hundred antipsychotic-treated young adults (between the age of 18 and 35), who are capable to undertake an exercise program (potentially with a friend or family member where possible) will be recruited from outpatient treatment units and mental health services. Participants will be randomised to treatment as usual or exercise at a 2:1 ratio in favor of exercise. Outcomes will be measured at baseline and at 4, 6 and 12 months after randomisation, by researchers masked to participant allocation.
Detailed Description
Background: Antipsychotic medications are associated with development of metabolic side-effects. Patients with schizophrenia have a four-fold higher prevalence of metabolic syndrome, and a two-to-three-fold higher risk of cardiovascular diseases compared to the general population. These factors may contribute to the premature mortality of 15-20 years observed in people with schizophrenia. The increased morbidity and mortality in people with mental illness can be explained by several risk factors, including physical inactivity. Evidence suggests that exercise can have beneficial effects on multiple cardiometabolic outcomes, and improve clinical symptoms, quality of life, global functioning, and reduce negative and depressive symptoms in people with schizophrenia. In general, greater effects are seen for higher doses of aerobic exercise and motivational theory-based interventions supervised by exercise professionals. However, because of strict inclusion criteria, the external validity of existing studies is limited, and effectiveness studies are urgently needed Objectives: The primary objective is to determine the effectiveness of participation in a four-month supervised, gym-based exercise program among people treated with antipsychotic medication compared to usual care on patient-rated recovery (primary outcome). Secondary objectives are to examine if the gym-based exercise program compared to usual care improves the following: Mental health Health-related quality of life Behavioral and functional symptoms Metabolic health As tertiary objectives, we will investigate if: Prolongation of subsidized gym membership in addition to motivational text messages (extended support) will be superior to subsidized gym membership alone (minimal support), and to treatment as usual in relation to post-intervention adoption of physical activity. The exercise program impacts the quality of life and physical and mental health of the participants' primary relative. Participation in the gym-based program is associated with a reduction in the participants' use of mental health care services. The exercise program is cost-effective. Design: This is a multi-center, pragmatic, randomized (1:2) superiority trial to compare a 4-month, supervised, gym-based exercise training program to usual care. The pragmatic nature of the trial entails that it is designed to evaluate the effectiveness of interventions in real-life routine practice conditions. In order to explore different ways to support sustainment (i.e., post-intervention adherence/adoption of physical activity), and to guide strategies to facilitate adherence, we will do "a study within a trial" (SWAT). Hence participants randomized to the intervention at baseline, will be randomized (allocation ratio 1:1) after four months to minimal vs. extended support with regards to sustainment of physical activity.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Affective Disorder, Psychosis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
400 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Vega Exercise Community
Arm Type
Experimental
Arm Description
Participants will be offered one hour of tailored supervised, gym-based exercise training three times per week for a period of four months. In addition, participants are offered free-of-charge membership to the gym for six months and are invited to take part in training classes and use fitness equipment provided by the gym to regular members. The supervised program is tailored to meet the needs and requirements of this particular group of young adults and will include three weekly sessions of moderate-to-high intensity and mobility exercises.
Arm Title
Usual care
Arm Type
No Intervention
Arm Description
Participants will receive treatment as usual and be informed of the official physical activity guidelines as part of the information on group allocation. Moreover, they will be advised to continue their daily living, as they normally would do, not guiding them to other interventions neither preventing them to do so. In addition, participants in the usual care group will be given a subsidized membership including access to the exercise classes for four months after the 12 months follow up.
Intervention Type
Behavioral
Intervention Name(s)
Supervised exercise
Intervention Description
The exercise sessions start with warm-up exercises, followed by 10-20 minutes resistance training (Part A), 10-20 minutes High Intensity Functional Training (HIFT) (Part B) and cool down. Instructors are allowed to make local adjustments as the delivery of the intervention is considered pragmatic. The participants can either perform the exercise together as one group, in pairs or one-by-one depending on individual needs and requests.
Primary Outcome Measure Information:
Title
Personal recovery
Description
15-item Questionnaire about the Process of Recovery
Time Frame
Baseline to four months
Secondary Outcome Measure Information:
Title
Personal recovery
Description
15-item Questionnaire about the Process of Recovery
Time Frame
Baseline to six months and 12 months
Title
Mental health
Description
Mental Component Summary from the Short-Form 12 (SF-12) Health survey
Time Frame
Baseline to four months
Title
Health-related quality of life
Description
Short-Form 12 (SF-12) Health survey
Time Frame
Baseline to four, six and 12 months
Title
Affective symptoms
Description
Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional distress
Time Frame
Baseline to four, six and 12 months
Title
Physical Activity
Description
International Physical Activity Questionnaire short form (IPAQ-SF)
Time Frame
Baseline to four, six and 12 months
Title
Internalized Stigma
Description
Internalized Stigma of Mental Illness Inventory (ISMI-9) short form
Time Frame
Baseline to four, six and 12 months
Title
Use of substance (alcohol, cannabis, drugs)
Description
Measured by self-developed items with responses for each substance: "never used", "use less than once a month", "regular use", "harmful use"
Time Frame
Baseline to four, six and 12 months
Title
Sleep
Description
Brief Pittsburgh Sleep Quality Index (B-PSQI)
Time Frame
Baseline to four, six and 12 months
Title
Positive and negative symptoms
Description
Colorado Symptom Index (MCSI)
Time Frame
Baseline to four, six and 12 months
Title
Loneliness
Description
Measured by a single item on a Likert scale of 4 levels: "During the past 12 months, have you felt lonely?"
Time Frame
Baseline to four, six and 12 months
Title
Abdominal circumference
Description
Measured with tape measure
Time Frame
Baseline to four, six and 12 months
Title
Body weight
Description
Measured on a scale
Time Frame
Baseline to four, six and 12 months
Title
Skeletal muscle mass
Description
Measured by bioimpedance
Time Frame
Baseline to four, six and 12 months
Title
Total body fat
Description
Measured by bioimpedance
Time Frame
Baseline to four, six and 12 months
Title
Cardiorespiratory fitness
Description
measured with the modified Ekblom-Bak submaximal cycle ergometer test
Time Frame
Baseline to four, six and 12 months
Title
Blood pressure
Description
measured by a digital blood pressure monitor
Time Frame
Baseline to four, six and 12 months
Title
Resting heart rate
Description
measured by a heart rate monitor
Time Frame
Baseline to four, six and 12 months
Title
High density lipoproteins (HDL)
Description
Taken from routine blood tests (mmol/l)
Time Frame
Baseline to four, six and 12 months
Title
Low density lipoproteins (LDL)
Description
Taken from routine blood tests (mmol/l)
Time Frame
Baseline to four, six and 12 months
Title
Triglycerides
Description
Taken from routine blood tests (mmol/l)
Time Frame
Baseline to four, six and 12 months
Title
Glycosylated haemoglobin (HbA1c)
Description
Taken from routine blood tests (mmol/l)
Time Frame
Baseline to four, six and 12 months
Title
C-reactive protein (CRP)
Description
Taken from routine blood tests (mg/L)
Time Frame
Baseline to four, six and 12 months
Other Pre-specified Outcome Measures:
Title
Use of the subsidized membership
Description
To explore if prolongation of subsidized gym membership in addition to motivational text messages (extended support) is superior to subsidized gym membership alone (minimal support), and to treatment as usual in relation to post-intervention adoption of physical activity measured by use of the subsidized membership (intervention group only)
Time Frame
four to six months
Title
Extended vs. minimal support for physical activity
Description
To explore if prolongation of subsidized gym membership in addition to motivational text messages (extended support) is superior to subsidized gym membership alone (minimal support), and to treatment as usual in relation to post-intervention adoption of physical activity measured by the IPAQ-SF (both groups).
Time Frame
four to six months
Title
Quality of life of primary relatives to participants
Description
To explore the impact of the Vega Exercise Community on the quality of life measured by SF-12 of the participants' primary relative
Time Frame
Baseline to four, six and 12 months
Title
Sleep of primary relatives to participants
Description
To explore the impact of the Vega Exercise Community on sleep (measured by B-PSQI) of the participants' primary relative
Time Frame
Baseline to four, six and 12 months
Title
Mental health of primary relatives to participants
Description
To explore the impact of the Vega Exercise Community on mental health (measured by PROMIS Emotional Distress-Depression - Short Form 4a) of the participants' primary relative
Time Frame
Baseline to four, six and 12 months
Title
Physical activity of primary relatives to participants
Description
To explore the impact of the Vega Exercise Community on physical activity (measured by IPAQ-SF) of the participants' primary relative
Time Frame
Baseline to four, six and 12 months
Title
Utilization of mental health care services
Description
To explore differences between groups of participants' long-term use of mental health care services, specifically number of inpatient and outpatient mental health contacts, including mental health emergency departments obtained from medical records
Time Frame
24 months and 60 months
Title
Cost of the Vega Exercise Community
Description
To explore the intervention cost i.e., education of instructors and delivery of exercise classes
Time Frame
Baseline to four, six and 12 months
Title
Cost-effectiveness of the Vega Exercise Community
Description
To explore the cost-effectiveness by comparing the cost and health-related quality of life, which will be measured by the EuroQol-5 Domain (EQ-5D)
Time Frame
Baseline to four, six and 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: diagnosed with a psychotic disorder (F20-F29 Schizophrenia, schizotypal and delusional disorders) or an affective disorder (F30-F39 Mood [affective] disorders) treated with antipsychotic medication (any dose) for at least one month able to read and speak Danish Exclusion Criteria: advised from participating in exercise training by their treating doctor
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Bolette Skjødt Rafn, PhD
Phone
22913873
Email
bolette.skjoedt.rafn@regionh.dk
First Name & Middle Initial & Last Name or Official Title & Degree
Julie Midtgaard, Prof.
Phone
24670445
Email
julie.midtgaard.klausen@regionh.dk
Facility Information:
Facility Name
Aalborg University Hospital
City
Aalborg
ZIP/Postal Code
9220
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bolette Skjødt Rafn
Phone
22913873
Email
bolette.skjoedt.rafn@regionh.dk
Facility Name
Aarhus University Hospital
City
Aarhus
ZIP/Postal Code
8200
Country
Denmark
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bolette Skjødt Rafn
Phone
22913873
Email
bolette.skjoedt.rafn@regionh.dk
Facility Name
Mental Health Centre Copenhagen
City
Copenhagen
ZIP/Postal Code
2100
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bolette Skjødt Rafn
Phone
22913873
Email
bolette.skjoedt.rafn@regionh.dk
Facility Name
Mental Health Centre Glostrup
City
Glostrup
ZIP/Postal Code
2600
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bolette Skjødt Rafn
Phone
22913873
Email
bolette.skjoedt.rafn@regionh.dk

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Value of Gym-based Exercise Training for Young Adults Receiving Antipsychotic Medication: The Vega Trial

We'll reach out to this number within 24 hrs